在阿尔茨海默病的污名化中的公众形象:没有支持,受到歧视,独自一人
Shana D Stites1,2, Carolyn Kuz1, Kristin Harkins2
1Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Journal of public health research
|November 18, 2025
概括
围绕阿尔茨海默病 (AD) 的公众耻辱可以通过解决关于缺乏支持和歧视的信念来减少. 信息应该考虑受众的年龄和教育,以有效地减少阿尔茨海默病的耻辱.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 公共卫生 公共卫生
背景情况:
- 与阿尔茨海默病 (AD) 相关的公众耻辱对寻求及时医疗帮助和参与关键研究构成重大障碍.
- 了解AD污名的细微模式对于开发有效的干预措施来减轻其负面影响至关重要.
研究的目的:
- 调查阿尔茨海默病污名化的各种方面模式.
- 确定旨在减少AD耻辱的公共信息的潜在目标.
主要方法:
- 一项相关研究涉及317名成年受访者,他们评估了一位患有早期阿尔茨海默氏症痴呆症的男子的照片.
- 利用阿尔茨海默氏症疾病尺度 (FS-ADS) 中的修改后的家庭耻辱来测量包括结构歧视,负重度属性,支持性和社会距离在内的维度.
- 采用隐性类分析来识别响应配置文件和回归模型,以将个人特征与配置文件成员关系起来.
主要成果:
- 隐性类别分析揭示了关于AD的三个不同的耻辱概况.
- 两个主要的个人资料,包括66.8%的参与者,主要是对AD患者的社会支持的期望有所不同.
- 个人资料成员身份与人口因素有关:较高的预期支持与识别为白人和低教育相关,而较低的预期支持与高等教育相关.
结论:
- 关于支持不足的信念,对歧视的担忧和预期的社会距离构成了公众宣传活动的凝聚性主题.
- 为了减少阿尔茨海默病的耻辱感,公共信息传递策略应该根据目标受众的年龄和教育背景进行量身定制.
相关概念视频
02:55Stereotypes, Prejudice, and Discrimination
94.8K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
94.8K
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
02:16Stereotype Content Model
15.3K
The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
15.3K
01:22Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772
01:30Negative and Cognitive Symptoms of Schizophrenia
416
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
416
01:30Dementia
498
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
498